1. Home
  2. IFBD vs LEXX Comparison

IFBD vs LEXX Comparison

Compare IFBD & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Infobird Co. Ltd

IFBD

Infobird Co. Ltd

HOLD

Current Price

$1.29

Market Cap

7.5M

Sector

Technology

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

N/A

Current Price

$3.42

Market Cap

8.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IFBD
LEXX
Founded
2001
2004
Country
China
Canada
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5M
8.7M
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
IFBD
LEXX
Price
$1.29
$3.42
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $1.50
AVG Volume (30 Days)
★ 425.9K
123.0K
Earning Date
05-01-2023
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $705,923.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$601.47
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 52.05
52 Week Low
$0.66
$0.35
52 Week High
$2.18
$14.37

Technical Indicators

Market Signals
Indicator
IFBD
LEXX
Relative Strength Index (RSI) 70.36 36.48
Support Level $0.87 $0.57
Resistance Level $2.18 $12.89
Average True Range (ATR) 0.22 1.15
MACD 0.03 -0.44
Stochastic Oscillator 35.21 7.18

Price Performance

Historical Comparison
IFBD
LEXX

About IFBD Infobird Co. Ltd

Infobird Co Ltd is a software-as-a-service (SaaS) provider of AI-powered customer engagement solutions in China. The Company provides standard and customized customer relationship management cloud-based services, including SaaS and business process outsourcing (BPO) services. It generates revenue from the development and sale of software licenses for customized software, as well as from business integration solution services and digital advertising and marketing campaign services. Digital advertising revenue is generated from developing and executing advertising plans based on customer needs, and the Company generally provides limited warranties for work performed under its business integration solution contracts. The Company generates maximum revenue from its operations in Mainland China.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: